Revenue
No reported data
IO Biotech, Inc. (IOBTQ)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
Free cash flow
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Research & development | $71.5M | $67.8M | $47.0M | $30.2M | $8.5M |
| Operating expenses | $95.2M | $91.4M | $71.4M | $41.2M | $10.1M |
| Operating income | −$95.2M | −$91.4M | −$71.4M | −$41.2M | −$10.1M |
| EBITDAderived | −$94.9M | −$91.2M | −$71.3M | −$41.2M | — |
| Net income | −$95.5M | −$86.1M | −$71.5M | −$67.9M | −$12.0M |
| Basic EPSper diluted share | -$1.45 | -$1.98 | -$2.48 | -$17.30 | -$82.36 |
| Diluted EPSper diluted share | -$1.45 | -$1.98 | -$2.48 | -$17.30 | -$82.36 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 30, 2025Form 4 | Hunter HeidiDirector | BuyCommon Stock | 15.0K | $1.39 | $20.9K | 15.0K |
| Dec 23, 2024Form 4 | Ahmad Qasim IftikharChief Medical Officer | BuyCommon Stock | 31.4K | $0.85 | $26.6K | 31.4K |
| Dec 23, 2024Form 4 | Zocca Mai-BrittChief Executive Officer | BuyCommon Stock | 12.5K | $0.81 | $10.1K | 49.9K |
| Dec 23, 2024Form 4 | Sullivan AmyChief Financial Officer | BuyCommon Stock | 10.3K | $0.83 | $8.5K | 84.6K |
| Dec 23, 2024Form 4 | Smith Devin WhittemoreGeneral Counsel | BuyCommon Stock | 12.0K | $0.81 | $9.7K | 16.9K |